ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 262 filers reported holding ACADIA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 1.06 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,119,413 | -13.1% | 53,778 | +0.0% | 0.00% | 0.0% |
| Q2 2023 | $1,288,224 | +27.8% | 53,766 | +0.3% | 0.00% | 0.0% |
| Q1 2023 | $1,008,186 | +159.9% | 53,598 | +119.8% | 0.00% | – |
| Q4 2022 | $387,909 | -2.6% | 24,381 | -50.0% | 0.00% | – |
| Q3 2022 | $398,398 | +14.5% | 48,764 | +97.4% | 0.00% | – |
| Q2 2022 | $348,000 | -99.4% | 24,699 | -98.9% | 0.00% | -100.0% |
| Q1 2022 | $55,590,000 | +16.9% | 2,295,276 | +12.7% | 0.03% | +35.0% |
| Q4 2021 | $47,543,000 | +46.6% | 2,036,981 | +4.4% | 0.02% | +42.9% |
| Q3 2021 | $32,420,000 | -31.1% | 1,951,858 | +1.2% | 0.01% | -30.0% |
| Q2 2021 | $47,052,000 | -66.1% | 1,929,131 | -64.1% | 0.02% | -68.3% |
| Q1 2021 | $138,735,000 | -48.9% | 5,377,376 | +5.8% | 0.06% | -50.0% |
| Q4 2020 | $271,735,000 | +15.4% | 5,082,912 | -10.9% | 0.13% | +2.4% |
| Q3 2020 | $235,378,000 | +24.2% | 5,706,104 | +45.9% | 0.12% | +16.0% |
| Q2 2020 | $189,517,000 | +201.1% | 3,909,963 | +162.4% | 0.11% | +146.5% |
| Q1 2020 | $62,948,000 | +1583.6% | 1,489,902 | +1334.1% | 0.04% | +2050.0% |
| Q3 2019 | $3,739,000 | -92.6% | 103,894 | -96.7% | 0.00% | -93.8% |
| Q4 2018 | $50,807,000 | -22.1% | 3,142,042 | -0.0% | 0.03% | -8.6% |
| Q3 2018 | $65,244,000 | +23.9% | 3,142,784 | -8.9% | 0.04% | +16.7% |
| Q2 2018 | $52,660,000 | -66.5% | 3,448,610 | -50.7% | 0.03% | -67.7% |
| Q1 2018 | $157,191,000 | -23.0% | 6,995,601 | +3.2% | 0.09% | -26.2% |
| Q4 2017 | $204,184,000 | -9.0% | 6,781,284 | +13.8% | 0.13% | -12.5% |
| Q3 2017 | $224,459,000 | +119.7% | 5,958,548 | +62.7% | 0.14% | +108.7% |
| Q2 2017 | $102,152,000 | – | 3,662,667 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Finepoint Capital LP | 556,553 | $11,598,565 | 5.78% |
| Baker Brothers Advisors | 42,864,612 | $893,298,514 | 5.15% |
| RTW INVESTMENTS, LP | 11,576,537 | $241,255,031 | 5.09% |
| Palo Alto Investors LP | 2,405,793 | $50,136,726 | 4.74% |
| Birchview Capital, LP | 240,400 | $5,009,936 | 4.26% |
| EcoR1 Capital, LLC | 5,991,479 | $124,862,422 | 4.21% |
| EMERALD ADVISERS, LLC | 1,681,052 | $35,033,124 | 1.70% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 1,303,988 | $27,175,110 | 1.64% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 179,702 | $3,739,599 | 1.26% |
| SECTOR GAMMA AS | 179,785 | $3,746,719 | 0.96% |